Assertio price target lowered to $1.50 from $1.75 at Alliance Global Partners

Alliance Global Partners lowered the firm’s price target on Assertio (ASRT) to $1.50 from $1.75 and keeps a Buy rating on the shares following the Q1 report. The company’s Q1 revenue was below forecast driven largely by Rolvedon, the analyst tells investors in a research note. Now that Assertio appears to have cleaned up the opioid overhang litigation, the share price should start tracking Rolvedon, for better or worse, contends Alliance Global .